Generation of soluble NKG 2 D ligands: proteolytic cleavage, exosome secretion and functional implications G Chitadze, J Bhat, M Lettau, O Janssen, D Kabelitz Scandinavian journal of immunology 78 (2), 120-129, 2013 | 209 | 2013 |
Shedding of endogenous MHC class I‐related chain molecules A and B from different human tumor entities: heterogeneous involvement of the “a disintegrin and metalloproteases” 10 … G Chitadze, M Lettau, J Bhat, D Wesch, A Steinle, D Fürst, J Mytilineos, ... International journal of cancer 133 (7), 1557-1566, 2013 | 204 | 2013 |
The ambiguous role of γδ T lymphocytes in antitumor immunity G Chitadze, HH Oberg, D Wesch, D Kabelitz Trends in immunology 38 (9), 668-678, 2017 | 76 | 2017 |
NKG2D-and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors G Chitadze, M Lettau, S Luecke, T Wang, O Janssen, D Fürst, J Mytilineos, ... Oncoimmunology 5 (4), e1093276, 2016 | 65 | 2016 |
In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment G Chitadze, C Flüh, ES Quabius, S Freitag-Wolf, C Peters, M Lettau, ... Oncoimmunology 6 (11), e1358839, 2017 | 45 | 2017 |
Intracellular pathways following uptake of bevacizumab in RPE cells SHA Naga, M Dithmer, G Chitadze, D Kabelitz, R Lucius, J Roider, ... Experimental eye research 131, 29-41, 2015 | 43 | 2015 |
NKG2D ligands in glioma stem-like cells: expression in situ and in vitro C Flüh, G Chitadze, V Adamski, K Hattermann, M Synowitz, D Kabelitz, ... Histochemistry and cell biology 149, 219-233, 2018 | 33 | 2018 |
Histone deacetylase inhibitor modulates NKG2D receptor expression and memory phenotype of human gamma/delta T cells upon interaction with tumor cells J Bhat, S Dubin, A Dananberg, ES Quabius, J Fritsch, CM Dowds, ... Frontiers in immunology 10, 569, 2019 | 24 | 2019 |
The impact of phenotypic heterogeneity of tumour cells on treatment and relapse dynamics M Raatz, S Shah, G Chitadze, M Brüggemann, A Traulsen PLoS Computational Biology 17 (2), e1008702, 2021 | 18 | 2021 |
Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4 M Lettau, M Dietz, S Vollmers, F Armbrust, C Peters, TM Dang, G Chitadze, ... Cellular and Molecular Life Sciences 77, 751-764, 2020 | 18 | 2020 |
Immune surveillance in glioblastoma: Role of the NKG2D system and novel cell‐based therapeutic approaches G Chitadze, D Kabelitz Scandinavian Journal of Immunology 96 (2), e13201, 2022 | 16 | 2022 |
The serine protease CD26/DPP4 in non-transformed and malignant T Cells G Chitadze, U Wehkamp, O Janssen, M Brüggemann, M Lettau Cancers 13 (23), 5947, 2021 | 14 | 2021 |
Signal strength of STING activation determines cytokine plasticity and cell death in human monocytes D Kabelitz, M Zarobkiewicz, M Heib, R Serrano, M Kunz, G Chitadze, ... Scientific Reports 12 (1), 17827, 2022 | 12 | 2022 |
Stochastics of cellular differentiation explained by epigenetics: the case of T‐cell differentiation and functional plasticity J Bhat, J Helmuth, G Chitadze, L Kouakanou, C Peters, M Vingron, ... Scandinavian Journal of Immunology 86 (4), 184-195, 2017 | 8 | 2017 |
A new view on minimal residual disease quantification in acute lymphoblastic leukemia using droplet digital PCR C Schwinghammer, J Koopmann, G Chitadze, L Karawajew, ... The Journal of Molecular Diagnostics 24 (8), 856-866, 2022 | 7 | 2022 |
Bispecific antibodies in acute lymphoblastic leukemia therapy G Chitadze, A Laqua, M Lettau, CD Baldus, M Brüggemann Expert review of hematology 13 (11), 1211-1233, 2020 | 6 | 2020 |
Erroneous expression of NKG2D on granulocytes detected by phycoerythrin‐conjugated clone 149810 antibody G Chitadze, M Lettau, C Peters, S Luecke, C Flüh, ES Quabius, ... Cytometry Part B: Clinical Cytometry 102 (3), 228-238, 2022 | 5 | 2022 |
Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia G Chitadze, A Stengel, C John-Klaua, J Bruckmüller, H Trautmann, ... Blood 141 (13), 1640-1644, 2023 | 4 | 2023 |
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL L Bastian, T Beder, MJ Barz, S Bendig, L Bartsch, W Walter, N Wolgast, ... Blood 143 (14), 1391-1398, 2024 | 3 | 2024 |
Droplet Digital PCR: A New View on Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia. C Schwinghammer, J Koopmann, G Chitadze, L Karawajew, ... The Journal of Molecular Diagnostics: JMD, S1525-1578 (22) 00145, 2022 | 1 | 2022 |